The DTC Advertising Market

A ranking of 2015's DTC Ads

A ranking of 2015's DTC Ads

Great DTC pharma advertising during the last year or so has been "sparse," says SSCG Media Group president Debbie Renner. Still, here are her top 10 picks for 2015.

Larry Dobrow on the Worst DTC ads of 2015

Larry Dobrow on the Worst DTC ads of 2015

One side effect (pun super-deliberately intended) of prompting pharma creatives to come up with new go-to visuals is that, well, not every idea or execution is a keeper.

2015 DTC spending: All the data in one place

2015 DTC spending: All the data in one place

Drugmakers spent 20% more on DTC ads in 2015 than in 2014. Eli Lilly was the top spender, shelling out $220.4 million to promote Cialis, its erectile dysfunction drug.

Drugmakers eye growing IBS market with DTC push

Drugmakers eye growing IBS market with DTC push

Three drugmakers are making big pushes for their second-line treatments as they eye a massive market with few new prescription drug options.

BMS CEO defends use of DTC to promote cancer drug

BMS CEO defends use of DTC to promote cancer drug

The drugmaker's CEO said the campaign helps dispel pessimism created from a history of cancer drugs that lack "significant value."

Tecfidera's DTC campaign boosts Web traffic and call volume

Tecfidera's DTC campaign boosts Web traffic and call volume

Biogen execs said a recently launched DTC campaign for Tecfidera is showing positive early signs.

Lilly kicks off DTC campaign for Trulicity

Lilly kicks off DTC campaign for Trulicity

The drugmaker aims to differentiate its type-2 diabetes drug in the competitive GLP-1 receptor agonist class.

BI and Lilly launch DTC campaign for Jardiance

BI and Lilly launch DTC campaign for Jardiance

The drugmakers worked with Evoke Health to develop a campaign that would differentiate the third-in-class type-2 diabetes drug in an increasingly competitive market.

Allergan sales rise on "strong" DTC advertising

Allergan sales rise on "strong" DTC advertising

Allergan executives attributed strong sales of branded products to recent investments in direct-to-consumer advertising.

Sanofi launches DTC campaign for Afrezza

Sanofi launches DTC campaign for Afrezza

The "Surprise, it's insulin" campaign follows criticism of the lower-than-expected sales of the inhaled insulin since its launch in February.

DTC expected to propel Afrezza awareness, not necessarily sales

DTC expected to propel Afrezza awareness, not necessarily sales

Havas Health developed the inhaled insulin's advertising campaign, which is slated to kick off later this summer.

Pfizer delivers strong Prevnar sales on back of big '15 consumer media outlay

Pfizer delivers strong Prevnar sales on back of big '15 consumer media outlay

Company's vaccines chief credits campaigns aimed at grownups with driving US demand for blockbuster vaccine. The remaining cohort will be harder to capture.

Pharma DTC spending jumps almost 21% in 2014

Pharma DTC spending jumps almost 21% in 2014

Nielsen data shows pharma spent $4.5 billion on DTC ads last year.

Let's talk about DTC

Podcast: Pfizer's and Bristol-Myers Squibb's "Cardiac Resuscitation"

Podcast: Pfizer's and Bristol-Myers Squibb's "Cardiac Resuscitation"

MM&M's Larry Dobrow talks to Michael Maher, president of ID Health, about the advertising for Eliquis. The DTC campaign launched last year.

Podcast: AstraZeneca's "Take it from a fish"

Podcast: AstraZeneca's "Take it from a fish"

MM&M's Jaimy Lee talks with Sudler & Hennessey's Rob Rogers, 2015 Lions Health pharma jury president, about what this campaign has to with the ongoing debate about creativity versus conservatism in pharma advertising.